ADVACAN 0.25MG TABLET

Advacan 0.25mg Tablet is an immunosuppressant medicine used to help prevent organ rejection in patients who have undergone kidney or liver transplantation. It contains Everolimus, an mTOR inhibitor that works by regulating the body’s immune response. By controlling immune activity, this medication supports the long-term success of transplanted organs when taken under strict medical supervision.

Advacan 0.25mg Tablet helps reduce the risk of the immune system attacking the newly transplanted organ. It is commonly prescribed in combination with other immunosuppressive agents to enhance protection and improve treatment outcomes. Consistent dosing and regular monitoring are essential to maintain optimal therapeutic levels and minimize complications.

Advacan 0.25mg Tablet ensures safety, effectiveness, and reliable performance. It is widely supplied to hospitals, pharmacies, and international markets for transplant care management. Always use this medication exactly as prescribed by a qualified healthcare professional.

Product Features

• Contains Everolimus 0.25mg
• Prevents organ rejection post-transplant
• mTOR inhibitor for immune regulation
• Used in combination transplant therapy
• High-quality pharmaceutical formulation

How It Helps

• Reduces risk of transplant rejection
• Controls overactive immune response
• Supports long-term graft survival
• Enhances effectiveness of combination therapy